» Articles » PMID: 21908407

Thiostrepton Inhibits Stable 70S Ribosome Binding and Ribosome-dependent GTPase Activation of Elongation Factor G and Elongation Factor 4

Overview
Specialty Biochemistry
Date 2011 Sep 13
PMID 21908407
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Thiostrepton, a macrocyclic thiopeptide antibiotic, inhibits prokaryotic translation by interfering with the function of elongation factor G (EF-G). Here, we have used 70S ribosome binding and GTP hydrolysis assays to study the effects of thiostrepton on EF-G and a newly described translation factor, elongation factor 4 (EF4). In the presence of thiostrepton, ribosome-dependent GTP hydrolysis is inhibited for both EF-G and EF4, with IC(50) values equivalent to the 70S ribosome concentration (0.15 µM). Further studies indicate the mode of thiostrepton inhibition is to abrogate the stable binding of EF-G and EF4 to the 70S ribosome. In support of this model, an EF-G truncation variant that does not possess domains IV and V was shown to possess ribosome-dependent GTP hydrolysis activity that was not affected by the presence of thiostrepton (>100 µM). Lastly, chemical footprinting was employed to examine the nature of ribosome interaction and tRNA movements associated with EF4. In the presence of non-hydrolyzable GTP, EF4 showed chemical protections similar to EF-G and stabilized a ratcheted state of the 70S ribosome. These data support the model that thiostrepton inhibits stable GTPase binding to 70S ribosomal complexes, and a model for the first step of EF4-catalyzed reverse-translocation is presented.

Citing Articles

Mode of Action and Mechanisms of Resistance to the Unusual Polyglycosylated Thiopeptide Antibiotic Persiathiacin A.

Woodgate J, Sumang F, Salliss M, Belousoff M, Ward A, Challis G ACS Infect Dis. 2024; 11(1):155-163.

PMID: 39651842 PMC: 11731312. DOI: 10.1021/acsinfecdis.4c00503.


Thiostrepton: multifaceted biological activities and its applications in treatment of inflammatory diseases.

Asikaer A, Sun C, Shen Y Inflammopharmacology. 2024; 33(1):183-194.

PMID: 39487942 DOI: 10.1007/s10787-024-01587-9.


Discovery and Biosynthesis of Persiathiacins: Unusual Polyglycosylated Thiopeptides Active Against Multidrug Resistant Tuberculosis.

Dashti Y, Mohammadipanah F, Zhang Y, Cerqueira Diaz P, Vocat A, Zabala D ACS Infect Dis. 2024; 10(9):3378-3391.

PMID: 39189814 PMC: 11406533. DOI: 10.1021/acsinfecdis.4c00502.


Hibernating ribosomes as drug targets?.

Ekemezie C, Melnikov S Front Microbiol. 2024; 15:1436579.

PMID: 39135874 PMC: 11317432. DOI: 10.3389/fmicb.2024.1436579.


An easy tool to monitor the elemental steps of in vitro translation via gel electrophoresis of fluorescently labeled small peptides.

Marina V, Bidzhieva M, Tereshchenkov A, Orekhov D, Sagitova V, Sumbatyan N RNA. 2024; 30(3):298-307.

PMID: 38164606 PMC: 10870375. DOI: 10.1261/rna.079766.123.


References
1.
Konevega A, Fischer N, Semenkov Y, Stark H, Wintermeyer W, Rodnina M . Spontaneous reverse movement of mRNA-bound tRNA through the ribosome. Nat Struct Mol Biol. 2007; 14(4):318-24. DOI: 10.1038/nsmb1221. View

2.
DONOVICK R, PAGANO J, Stout H, Weinstein M . Thiostrepton, a new antibiotic. I. In vitro studies. Antibiot Annu. 1955; 3:554-9. View

3.
Nicolaou K, Zak M, Rahimipour S, Estrada A, Lee S, OBrate A . Discovery of a biologically active thiostrepton fragment. J Am Chem Soc. 2005; 127(43):15042-4. DOI: 10.1021/ja0552803. View

4.
Schoof S, Pradel G, Aminake M, Ellinger B, Baumann S, Potowski M . Antiplasmodial thiostrepton derivatives: proteasome inhibitors with a dual mode of action. Angew Chem Int Ed Engl. 2010; 49(19):3317-21. DOI: 10.1002/anie.200906988. View

5.
Lill R, Robertson J, Wintermeyer W . Affinities of tRNA binding sites of ribosomes from Escherichia coli. Biochemistry. 1986; 25(11):3245-55. DOI: 10.1021/bi00359a025. View